一种经过验证的临床基因评分，用于评估接受血栓预防的COVID-19患者的血栓形成风险。 - Suppr

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis.

作者信息

Soria José Manuel, Mojal Sergi, Martinez-Perez Angel, Acosta Francisco René, López Sonia, Miqueleiz Sara, Rodriguez Diana, Quijada Maria Angeles, Cardenas Antonio, Vidal Francisco, Remacha Angel, Antonijoan Rosa Maria, Souto Juan Carlos

机构信息

Genomics of Complex Diseases Unit, Research Institute of Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona.

Haemostasis and Thrombosis Unit, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona.

出版信息

Haematologica. 2022 Sep 1;107(9):2244-2248. doi: 10.3324/haematol.2022.281068.

DOI:10.3324/haematol.2022.281068

PMID:35545920

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9425308/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8d/9425308/756c062c616b/1072244.fig1.jpg

相似文献

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis.一种经过验证的临床基因评分，用于评估接受血栓预防的COVID-19患者的血栓形成风险。

Haematologica. 2022 Sep 1;107(9):2244-2248. doi: 10.3324/haematol.2022.281068.

Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.3型血管性血友病合并重症新型冠状病毒肺炎感染患者的一级血栓预防

Haemophilia. 2021 Jul;27(4):e517-e519. doi: 10.1111/hae.14252. Epub 2021 Jan 11.

Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.2022 年 COVID-19 相关血栓形成：当前文献的更新叙述性综述及住院患者管理。

R I Med J (2013). 2022 Aug 1;105(6):36-40.

Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.癌症合并 COVID-19 患者的血栓栓塞性疾病：风险因素、预防和实用的血栓预防推荐建议——最新进展。

Anticancer Res. 2022 Jul;42(7):3261-3274. doi: 10.21873/anticanres.15815.

Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children.儿童血栓形成和止血的问题：住院儿童静脉血栓栓塞风险分层的方法和原因。

Thromb Res. 2018 Dec;172:190-193. doi: 10.1016/j.thromres.2018.02.010. Epub 2018 Feb 17.

Myeloma and thrombotic complications.多发性骨髓瘤与血栓并发症。

Minerva Med. 2013 Apr;104(2):155-60.

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.COVID-19 患者接受抗栓治疗时的静脉血栓栓塞症的系统评估：发生率和 D-二聚体作为预测因素的作用。

J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z.

Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary Prophylaxis.癌症患者的血栓形成风险：临床因素及一级预防的作用

Cancer Treat Res. 2019;179:55-68. doi: 10.1007/978-3-030-20315-3_4.

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19.没有证据表明有静脉血栓栓塞病史的患者在接种新冠病毒疫苗后血栓形成复发率会增加。

Thromb Res. 2022 Jun;214:44-46. doi: 10.1016/j.thromres.2022.04.010. Epub 2022 Apr 20.

Cancer-associated thrombosis.癌症相关性血栓形成。

Hematol Oncol Clin North Am. 2010 Aug;24(4):695-707, viii. doi: 10.1016/j.hoc.2010.05.004.

本文引用的文献

Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19.COVID-19住院患者和非住院患者静脉血栓栓塞症的诊断时机

Thromb Res. 2021 Nov;207:150-157. doi: 10.1016/j.thromres.2021.09.021. Epub 2021 Oct 7.

Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations.临床遗传风险评分对北欧和南欧人群静脉血栓栓塞的预测能力

TH Open. 2021 Jul 8;5(3):e303-e311. doi: 10.1055/s-0041-1729626. eCollection 2021 Jul.

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.COVID-19 重症监护患者中中剂量与标准剂量预防抗凝对血栓事件、体外膜肺氧合治疗或死亡率的影响：INSPIRATION 随机临床试验。

JAMA. 2021 Apr 27;325(16):1620-1630. doi: 10.1001/jama.2021.4152.

The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19.ABO 血型与 COVID-19 疾病严重程度和多器官功能障碍指标的关联。

Blood Adv. 2020 Oct 27;4(20):4981-4989. doi: 10.1182/bloodadvances.2020002623.

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.成人新冠肺炎住院患者的D-二聚体临界值与静脉血栓栓塞风险

Thromb Res. 2020 Dec;196:318-321. doi: 10.1016/j.thromres.2020.09.022. Epub 2020 Sep 17.

Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.用于预测危重症 COVID-19 患者静脉血栓栓塞症的生物标志物。

Thromb Res. 2020 Dec;196:308-312. doi: 10.1016/j.thromres.2020.09.017. Epub 2020 Sep 15.

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis.COVID-19 患者的静脉血栓栓塞症：系统评价和荟萃分析。

Thromb Res. 2020 Dec;196:67-74. doi: 10.1016/j.thromres.2020.08.020. Epub 2020 Aug 12.

Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis.接受血栓预防的COVID-19住院患者的静脉血栓栓塞：一项系统评价和荟萃分析

J Clin Med. 2020 Aug 3;9(8):2489. doi: 10.3390/jcm9082489.

Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.科学与标准化委员会通讯：新型冠状病毒肺炎住院患者静脉血栓栓塞症诊断、预防及治疗的临床指南

J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929.

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.基因组和转录组关联研究确定了 16 个静脉血栓栓塞的新易感性位点。

Blood. 2019 Nov 7;134(19):1645-1657. doi: 10.1182/blood.2019000435.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献